https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
0
0
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Marketing Team2023-09-25 11:50:082023-09-25 11:50:41Optimum’s top takeaways: Alchemab’s CEO Young Kwon featured on pharmaphorum podcastOptimum’s top takeaways: Alchemab’s CEO Young Kwon featured on pharmaphorum podcast
Alchemab’s CEO Young Kwon has appeared on the leading pharma…
Brace yourself for the busiest week in biopharma!
More than hangover-busting aspirin will be in order at the…
Investor Perspectives: Eva Haas gives her views on biopharma market trends in 2023
In the latest podcast episode, Optimum Strategic Communications’…
Sector Moves: August 2023
Analysts and Banking
Edward Sham has left their…
Edward Sham has left their…
Alchemab: The UK biotech that is revolutionising drug discovery
Alchemab is a Cambridge biotech that aims to revolutionise drug…
iOnctura: realising the potential of autotaxin therapy in cancer
There’s an increasing focus on using drugs to modify the tumour…
Poolbeg Pharma: Using AI to prepare for the next pandemic
No-one is likely to forget the tragic events of 2020 and…
Sector Moves: July 2023
Investment firms
Medicxi has raised $400M for Medicxi…
Medicxi has raised $400M for Medicxi…
Verona Pharma: Preparing a potentially novel COPD medicine for market
A much-anticipated new potential drug for COPD moved a step…
A ‘world without disease’ – a great aspiration, but how can we pay for it?
Is a world without disease possible?
That was the question…
That was the question…
New Horizons for Bio Innovation: Top takeaways from OnHelix 2023
One Nucleus’ On Helix Conference 2023, provided insight…
The ‘must-attend’ Healthcare conferences Autumn / Winter 2023
It is quite astonishing just how quick time flies - so let’s…
Link to: Optimum Perspectives Podcast
The Optimum Perspectives Podcast
New episode! Listen as Optimum’s Eva Haas and Richard Staines discuss the hot areas for investment in the shifting biotech market – including antibody-drug conjugates, smart radiotherapies, mRNA and immune-oncology.
7 September 2023
Optimum’s 15th Annual Healthcare Investor Conference 2023
Now in its 15th year, the conference brings together top executives and business leaders from the life sciences and investment communities.
11 July 2023
Link to: The ‘must-attend’ Healthcare conferences Autumn / Winter 2023
The ‘must-attend’ Healthcare conferences Autumn / Winter 2023
Sachs, LSX, Genesis and more… As an official supporter to many of the top events, Optimum is pleased to be able to provide discount codes to its network.
15 September 2023
Insights
We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
Optimum’s top takeaways: Alchemab’s CEO Young Kwon featured on pharmaphorum podcast
/in InsightsBrace yourself for the busiest week in biopharma!
/in InsightsInvestor Perspectives: Eva Haas gives her views on biopharma market trends in 2023
/in InsightsSector Moves: August 2023
/in InsightsAlchemab: The UK biotech that is revolutionising drug discovery
/in InsightsiOnctura: realising the potential of autotaxin therapy in cancer
/in Insights